The role of BRAF mutations in primary melanoma growth rate and survival

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2133|173|1|76-82

ISSN： 0007-0963

Source： BRITISH JOURNAL OF DERMATOLOGY, Vol.173, Iss.1, 2015-07, pp. : 76-82

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

B-raf Exon 15 Mutations Are Common in Primary Melanoma Resection Specimens but Not Associated with Clinical Outcome

By  

Oncology, Vol. 66, Iss. 5, 2004-09 ,pp. : 411-419

Karger

Access to resources Recommend Favorite

A primary melanoma and its asynchronous metastasis highlight the role of BRAF, CDKN2A, and TERT

By  

JOURNAL OF CUTANEOUS PATHOLOGY, Vol. 42, Iss. 2, 2015-02 ,pp. : 108-117

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanoma

By  

CANCER, Vol. 119, Iss. 21, 2013-11 ,pp. : 3821-3829

John Wiley & Sons Inc

Access to resources Recommend Favorite

A novel BRAF mutation in association with primary amelanotic melanoma with oral metastases

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 2, 2015-02 ,pp. : 387-390

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinicopathologic features associated with efficacy and long‐term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitors

By  

CANCER, Vol. 121, Iss. 21, 2015-11 ,pp. : 3826-3835

John Wiley & Sons Inc

Access to resources Recommend Favorite